Low-Dose CAR-T Shows Efficacy in Pediatric Systemic Lupus ...

MD Magazine - 29 Oct 2024
Four of 5 participants with follow-up reaching 3 months have achieved SRI-4 disease responses.

Nara Smith Opens Up About Struggles With Eczema and Lupus

PEOPLE - 20 Nov 2024
Nara Smith Opens Up About Struggles With Eczema and Lupus ...

New initiative aims to explore diet’s role in lupus care

News-Medical.Net - 23 Nov 2024
New initiative aims to explore diet’s role in lupus care ...

Beloit woman defies death, lupus after giving birth

MyStateline.com - 23 Nov 2024
Beloit woman defies death, lupus after giving birth ...

Biogen Gains Momentum With Positive Lupus Drug Results, Analyst Sees Modest Valuation Upside

Yahoo Finance - 20 Nov 2024
Biogen Gains Momentum With Positive Lupus Drug Results, Analyst Sees Modest Valuation Upside ...

House Creator Has An Explanation For Why Dr. House Diagnosed Cases With Lupus First

Screen Rant - 22 Nov 2024
House Creator Has An Explanation For Why Dr. House Diagnosed Cases With Lupus First ...

Nara Smith reveals she started cooking from scratch because of struggles with lupus, eczema: ‘Forced me to…’

Hindustan Times - 21 Nov 2024
Nara Smith reveals she started cooking from scratch because of struggles with lupus, eczema: ‘Forced me to…’ ...

‘Exciting’ new lupus treatment could end need for lifelong medication

The Guardian - 08 Nov 2024
‘Exciting’ new lupus treatment could end need for lifelong medication ...

CAR T for Lupus Takes Center Stage at ACR 2024

BioSpace - 19 Nov 2024
CAR T for Lupus Takes Center Stage at ACR 2024 ...

Lupus Research Highlights From American College of Rheumatology’s 2024 Scientific Meeting

Lupus Foundation of America - 19 Nov 2024
Lupus Research Highlights From American College of Rheumatology’s 2024 Scientific Meeting ...

2D4, a humanized monoclonal antibody targeting CD132, is a promising treatment for systemic lupus erythematosus

Nature.com - 17 Nov 2024
2D4, a humanized monoclonal antibody targeting CD132, is a promising treatment for systemic lupus erythematosus ...

Lupus Therapeutics Statement on Phase 3 PHOENYCS GO Positive Data in Moderate-To-Severe Systemic Lupus

PR Newswire - 19 Nov 2024
Lupus Therapeutics Statement on Phase 3 PHOENYCS GO Positive Data in Moderate-To-Severe Systemic Lupus ...

Unique Immune Response in Lupus Paves Way for New Treatment

Weill Cornell Medicine Newsroom - 15 Oct 2024
Unique Immune Response in Lupus Paves Way for New Treatment ...

Adicet Bio Announces First Lupus Nephritis Patient Dosed in Phase 1 Clinical Trial of ADI-001 in Autoimmune Diseases

Business Wire - 18 Nov 2024
Adicet Bio Announces First Lupus Nephritis Patient Dosed in Phase 1 Clinical Trial of ADI-001 in Autoimmune Diseases ...

BMS' CAR-T cracks down on lupus, achieving sustained responses in phase 1

Fierce Biotech - 14 Nov 2024
BMS' CAR-T cracks down on lupus, achieving sustained responses in phase 1 ...

Prognosis and Life Expectancy

Lupus Foundation of America - 14 Nov 2024
Prognosis and Life Expectancy ...

Scientists discover a cause of lupus and a possible way to reverse it

Northwestern Now - 10 Jul 2024
Scientists discover a cause of lupus and a possible way to reverse it ...

Multimarker Urine Test Promises to Improve Lupus Nephritis Diagnosis, Prognosis

Medpage Today - 18 Nov 2024
Multimarker Urine Test Promises to Improve Lupus Nephritis Diagnosis, Prognosis ...

Biogen, UCB Reveal Details Behind Surprise Late-Stage Win in Lupus, Eyes Second Phase III

BioSpace - 19 Nov 2024
Biogen, UCB Reveal Details Behind Surprise Late-Stage Win in Lupus, Eyes Second Phase III ...

Machine learning identifies cytokine signatures of disease severity and autoantibody profiles in systemic lupus erythematosus – a pilot study

Nature.com - 20 Nov 2024
Machine learning identifies cytokine signatures of disease severity and autoantibody profiles in systemic lupus erythematosus – a pilot study ...

Lupus